一个新的群体药理动力学模型,用于优化在耐火性患者中使用佐尼萨米德的剂量
Rui Silva1, Helena Colom2, Anabela Almeida3
1Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, Portugal; CIBIT/ICNAS Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, Portugal.
概括
种群药动力学 (PopPK) 模型有助于优化时的西胺剂量. 诱导酶的抗发作药物增加佐尼萨米德的清除,需要更高的剂量治疗水平.
科学领域:
- 药理动力学 药理动力学
- 药理学 药理学是指药理学的学科.
- 治疗的方法 治疗
背景情况:
- 由于显著的药理动力学变异性,尼胺的剂量具有挑战性.
- 种群药动力学 (PopPK) 模型对于理解药物处置因素至关重要.
研究的目的:
- 开发和验证一种PopPK模型,用于在耐火性中治疗佐尼萨米德.
- 优化佐尼萨米德的剂量和指导个性化剂量策略.
主要方法:
- 非线性混合效应建模方法使用来自64名患者的114个佐尼萨米德度.
- 采用了具有第一阶段淘汰的单间模型.
- 模型验证包括良性合适图,视觉预测检查和引导重新抽样.
主要成果:
- 最终的PopPK模型确定了清除 (CL/F),分布体积 (Vd/F) 和吸收速率常数 (ka) 的患者间变异性.
- 同时服用诱导酶的抗发作药物 (EIASDs) 显著增加了CL/F.
- 患有EIASD的患者需要更高的zonizamide剂量来达到治疗度.
结论:
- 经过验证的PopPK模型是一个强大的工具,可以在耐火性的成年人中个性化给定佐尼萨米德剂量.
- EIASDs需要调整剂量以保持治疗疗效.
- 优化剂量可以改善耐性患者的治疗结果.
相关概念视频
Pharmacokinetic Models: Overview
573
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
573
Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Nonlinear Pharmacokinetics: Overview
256
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
256
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
78
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
78
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Analysis of Population Pharmacokinetic Data
222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222


